Categories
MSU Bioethics on Facebook
Tweets
- RT @MSUMD: The @MSUGranFondo's six-year fundraising total is closing in on $1M! Every single dollar raised helps our scientists conduct gro… 14 hours ago
- Our free archive of recorded #bioethics webinars contains lectures on a wide variety of topics from expert speakers: bioethics.msu.edu/brownbag-webin… 14 hours ago
- From @NEJM: "As physicians, we strive to treat all our patients equally. It is imperative that we do the same for o… twitter.com/i/web/status/1… 16 hours ago
- Can brain scans spot criminal intent? msubioethics.com/2017/04/06/can… #BioethicsInTheNews #neuroethics 17 hours ago
- Social Determinants of Behavioral Health - from @MSUPubHealth's Dr. Debra Furr-Holden bioethics.msu.edu/90-brownbags/r… #video #bioethics 18 hours ago
Top Posts & Pages
Archives
Meta
Tag Archives: cancer treatment
Greed Is God: The Divine Right to Avaricious Drug Pricing
This post is a part of our Bioethics in the News series By Leonard M. Fleck, PhD Some recent headlines worth noting: “U.S. Prescription Drug Costs Are a Crime,” “Americans Say They are Suffering as Drug Costs Continue to Rise,” “When … Continue reading
Dr. Fleck presents at Great Lakes Biorepository Research Network annual scientific meeting
Center Professor Len Fleck, PhD, was a keynote speaker at the Great Lakes Biorepository Research Network (GLBRN) Annual Scientific Meeting, held at Beaumont Hospital-Royal Oak Campus on November 3. The title of Dr. Fleck’s presentation was “Precision Medicine, Ethical Ambiguity,” … Continue reading
Just Caring: Health Reform, Cost Control, and the Fate of Children with Life-Altering Illnesses
Center Professor Dr. Leonard Fleck recently gave a keynote address at the 2017 Pediatric Bioethics Day at Norton Children’s Hospital in Louisville, KY, held on September 20. Titled “Just Caring: Health Reform, Cost Control, and the Fate of Children with … Continue reading
Rights and Responsibilities at the End of Life
By Hannah Giunta, MPH, PhD
Questions about end-of-life care are always vexing, but a recent article in U.S. News and World Report suggests that cancer patients continue to receive useless but harmful treatments at the end of life (Thompson, 2016). A new research study presented at the American Society of Clinical Oncology’s (ASCO’s) annual meeting revealed that a big part of the problem comes from a lack of meaningful dialogue among physicians, patients, and family members. Continue reading
Patients’ Survival Expectations With and Without Their Chosen Treatment for Prostate Cancer
Center Professor Emerita Dr. Margaret Holmes-Rovner is a contributing author on a new article published in Annals of Family Medicine, “Patients’ Survival Expectations With and Without Their Chosen Treatment for Prostate Cancer.” Published in the May/June 2016 issue, the study is … Continue reading
Posted in Articles, Publications, Uncategorized
Tagged Annals of Family Medicine, bioethics, cancer, cancer treatment, Margaret Holmes-Rovner, prostate cancer
Precision Medicine/Ambiguous Ethics?
This post is a part of our Bioethics in the News series. For more information, click here. By Leonard Fleck, PhD In his State of the Union Address President Obama announced that he wished to set aside $215 million for his … Continue reading
Posted in Bioethics in the News
Tagged cancer, cancer treatment, genome, Imatinib, Leonard Fleck, precision medicine
11 Comments
